Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;50(12):4182-5.
doi: 10.1128/AAC.00714-06. Epub 2006 Oct 2.

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens

Florence Doualla-Bell  1 , Ava Avalos, Bluma Brenner, Tendani Gaolathe, Madisa Mine, Simani Gaseitsiwe, Maureen Oliveira, Daniella Moisi, Ndwapi Ndwapi, Howard Moffat, Max Essex, Mark A Wainberg
Affiliations

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens

Florence Doualla-Bell et al. Antimicrob Agents Chemother. 2006 Dec.

Abstract

We analyzed the reverse transcriptase genotypes of human immunodeficiency virus type 1 subtype C viruses isolated from 23 patients in Botswana treated with didanosine-based regimens. The K65R mutation was selected either alone or together with the Q151M, S68G, or F116Y substitution in viruses from seven such individuals. The results of in vitro passage experiments were consistent with an apparent increased propensity of subtype C viruses to develop the K65R substitution.

PubMed Disclaimer

References

    1. Abecasis, A. B., K. Deforche, J. Snoeck, L. T. Bacheler, P. McKenna, A. P. Carvalho, P. Gomes, R. J. Camacho, and A. M. Vandamme. 2005. Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G. AIDS 19:1799-1806. - PubMed
    1. Brenner, B., M. Oliveira, F. Doualla-Bell, D. Moisi, M. Ntemgwa, F. Frankel, M. Essex, and M. A. Wainberg. 2006. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS 20:F9-F13. - PubMed
    1. Brenner, B., D. Turner, M. Oliveira, D. Moisi, M. Detorio, M. Carobene, R. G. Marlink, J. Schapiro, M. Roger, and M. A. Wainberg. 2003. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 17:F1-F5. - PubMed
    1. Chaix, M. L., D. Descamps, M. Harzic, V. Schneider, C. Deveau, C. Tamalet, I. Pellegrin, J. Izopet, A. Ruffault, B. Masquelier, L. Meyer, C. Rouzioux, F. Brun-Vezinet, and D. Costagliola. 2003. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 17:2635-2643. - PubMed
    1. Doualla-Bell, F., S. Gaseitsiwe, T. Ndungu, M. Modukanele, T. Peter, V. A. Novitsky, N. Ndwapi, G. Tendani, A. Avalos, W. Wester, H. Bussmann, P. Cardiello, R. Marlink, H. Moffat, I. Thior, M. A. Wainberg, and M. Essex. 2004. Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients. Antivir. Chem. Chemother. 15:189-200. - PubMed